NasdaqGM:CRVSBiotechs
Corvus Pharmaceuticals (CRVS) Valuation Check After A Sharp Biotech Share Price Surge
Market context and recent performance
Corvus Pharmaceuticals (CRVS) has drawn investor attention after a sharp share price move, with the stock up 7.35% in the latest session and posting significant gains over the past month.
See our latest analysis for Corvus Pharmaceuticals.
The latest move sits within a very strong run, with a 30 day share price return of 201.33% and year to date share price return of 179.51%. The 1 year total shareholder return of 306.76% and very large 3 year total...